Suppr超能文献

可注射的泊洛沙姆-α-环糊精超分子凝胶用于万古霉素的持续递送。

Syringeable Pluronic-α-cyclodextrin supramolecular gels for sustained delivery of vancomycin.

机构信息

Department of Pharmaceutical Technology, University of Coimbra, Coimbra, Portugal.

出版信息

Eur J Pharm Biopharm. 2012 Jan;80(1):103-12. doi: 10.1016/j.ejpb.2011.09.017. Epub 2011 Oct 8.

Abstract

The ability of Pluronic® F127 to form supramolecular gels in the presence of αCD has been explored as a way to design syringeable gel formulations able to sustain drug release while using the lowest proportion of both components. The effects of αCD concentration range (0-9.7% w/v) in copolymer (6.5%, 13% and 20%) gel features were evaluated at 4, 20 and 37°C. An effective complexation of Pluronic and αCD was evidenced as a change in the surface pressure of the π-A isotherm of Pluronic on a subphase of CD solution and the apparition of new peaks in the X-ray spectra. Once the Pluronic and αCD solutions were mixed, the systems became progressively turbid solutions or white gels. The greater the αCD concentration was, the faster the gel formation. The supramolecular hydrogels were thixotropic and those containing 5% or more αCD had G' values above G″ at room temperature, but they were still easily syringeable. The values of both moduli increased as temperature raised; the effect being more evident for 13% and 20% w/v copolymer. The gels prepared with low proportions of αCD exhibited phase separation in few days, particularly when stored at 4 or 37 °C. By contrast, those prepared with 6.5% copolymer were stable for at least two months when stored at 20 °C. The gels were able to sustain vancomycin release for several days; the higher the αCD proportion, the slower the release was. Furthermore, the drug-loaded gels showed activity against Staphylococcus aureus. The results obtained highlight the role of the αCD concentration on the tuning of the rheological features and drug release profiles from Pluronic gels.

摘要

研究了 Pluronic® F127 在 αCD 存在下形成超分子凝胶的能力,以期设计出可注射凝胶制剂,在使用最低比例的两种成分的同时能够维持药物释放。在 4、20 和 37°C 下,评估了 αCD 浓度范围(0-9.7%w/v)对共聚物(6.5%、13%和 20%)凝胶特性的影响。Pluronic 与 αCD 的有效络合表现为 Pluronic 在 CD 溶液亚相上的π-A 等温线上表面压力的变化,以及 X 射线光谱中出现新峰。一旦 Pluronic 和 αCD 溶液混合,系统就会变成逐渐变混浊的溶液或白色凝胶。αCD 浓度越高,凝胶形成越快。超分子水凝胶是触变的,含有 5%或更多 αCD 的水凝胶在室温下 G'值高于 G″,但仍易于注射。随着温度的升高,两个模量的值都增加;对于 13%和 20%w/v 共聚物,这种影响更为明显。在几天内,低比例 αCD 制备的凝胶会发生相分离,特别是在 4 或 37°C 下储存时。相比之下,在 20°C 下储存时,用 6.5%共聚物制备的凝胶至少稳定两个月。凝胶能够维持数天的万古霉素释放;αCD 比例越高,释放越慢。此外,载药凝胶对金黄色葡萄球菌表现出活性。研究结果强调了 αCD 浓度在调节 Pluronic 凝胶流变特性和药物释放曲线方面的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验